| 0 (0%) | 02-21 18:47 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.63 | 1-year : | 7.47 |
| Resists | First : | 3.96 | Second : | 6.4 |
| Pivot price | 2.46  |
|||
| Supports | First : | 0.02 | Second : | 0.02 |
| MAs | MA(5) : | 2.44  |
MA(20) : | 1.86 |
| MA(100) : | 1.42 |
MA(250) : | 1.8 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 36.6 |
D(3) : | 37.7 |
| RSI | RSI(14): 56.7 |
|||
| 52-week | High : | 6.98 | Low : | 0.02 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SXTC ] has closed above bottom band by 47.9%. Bollinger Bands are 225.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 12 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 2.4 - 2.41 | 2.41 - 2.43 |
| Low: | 2.13 - 2.15 | 2.15 - 2.17 |
| Close: | 2.34 - 2.38 | 2.38 - 2.4 |
Fri, 13 Feb 2026
SXTC-DYADICA Global Brand Consulting Declare the New Battlefield of Branding: The Creation of their Brand Warfare Unit™ - SouthCoastToday.com
Tue, 03 Feb 2026
China SXT Pharmaceuticals (NASDAQ:SXTC) Shares Gap Down - Here's What Happened - MarketBeat
Tue, 03 Feb 2026
+39% after hours Most Active: SXTC China SXT Pharm NASDAQ 02/02/26: watch float - Meyka
Mon, 02 Feb 2026
Here’s Why China SXT Pharmaceuticals Stock (SXTC) Rocketed Today - TipRanks
Mon, 02 Feb 2026
Why SXTC Shares Surge? - Nasdaq
Fri, 30 Jan 2026
This Nano-cap Pharma Stock Crashed 30% Today – What Triggered The Sell-off? - Stocktwits
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 128 (M) |
| Held by Insiders | 8.206e+007 (%) |
| Held by Institutions | 32 (%) |
| Shares Short | 150 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -8.34e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 11.6 % |
| Return on Equity (ttm) | -18.3 % |
| Qtrly Rev. Growth | 1.54e+006 % |
| Gross Profit (p.s.) | -17.5 |
| Sales Per Share | -35.93 |
| EBITDA (p.s.) | 238850 |
| Qtrly Earnings Growth | -0.3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.07 |
| Price to Cash Flow | 19.55 |
| Dividend | 0 |
| Forward Dividend | 3.41e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|